BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26241430)

  • 1. Obstacles to Studying Emerging Technologies.
    Waetjen LE; Parvataneni R; Varon S; Saberi NS; Jacoby VL;
    Obstet Gynecol; 2015 Aug; 126(2):391-395. PubMed ID: 26241430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas: Clinical Outcomes during Early Adoption into Surgical Practice.
    Jacoby VL; Parvataneni R; Oberman E; Saberi NS; Varon S; Schembri M; Waetjen LE
    J Minim Invasive Gynecol; 2020; 27(4):915-925. PubMed ID: 31376584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System.
    Garza Leal JG; Hernandez Leon I; Castillo Saenz L; Lee BB
    J Minim Invasive Gynecol; 2011; 18(3):364-71. PubMed ID: 21545960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up.
    Wu XJ; Guo Q; Cao BS; Tan LX; Zhang HY; Cai YR; Gao BL
    Radiology; 2016 Jun; 279(3):952-60. PubMed ID: 26694049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy.
    Brucker SY; Hahn M; Kraemer D; Taran FA; Isaacson KB; Krämer B
    Int J Gynaecol Obstet; 2014 Jun; 125(3):261-5. PubMed ID: 24698202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency Ablation of Leiomyomas.
    Stewart KA; Greenberg JA; Kho KA; Cohen Rassier SL
    Obstet Gynecol; 2023 Jun; 141(6):1063-1071. PubMed ID: 37053594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA likely to further restrict or ban morcellation.
    Brower V
    Lancet Oncol; 2014 Aug; 15(9):e369. PubMed ID: 25225696
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-Market Safety of Laparoscopic Ultrasound-Guided Radiofrequency Ablation.
    Yu S; Silverberg K; Bhagavath B; Shobeiri SA; Propst A; Eisenstein D
    JSLS; 2020; 24(4):. PubMed ID: 33510567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis.
    Lin L; Ma H; Wang J; Guan H; Yang M; Tong X; Zou Y
    J Minim Invasive Gynecol; 2019; 26(3):409-416. PubMed ID: 30253997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally Invasive Approaches to Myoma Management.
    Gingold JA; Gueye NA; Falcone T
    J Minim Invasive Gynecol; 2018 Feb; 25(2):237-250. PubMed ID: 28734973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas.
    Bergamini V; Ghezzi F; Cromi A; Bellini G; Zanconato G; Scarperi S; Franchi M
    Am J Obstet Gynecol; 2005 Mar; 192(3):768-73. PubMed ID: 15746670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up.
    Robles R; Aguirre VA; Argueta AI; Guerrero MR
    Int J Gynaecol Obstet; 2013 Jan; 120(1):65-9. PubMed ID: 23073229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Series of Reproductive Outcomes after Laparoscopic Radiofrequency Ablation of Symptomatic Myomas.
    Berman JM; Shashoua A; Olson C; Brucker S; Thiel JA; Bhagavath B
    J Minim Invasive Gynecol; 2020; 27(3):639-645. PubMed ID: 31238151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation for symptomatic uterine leiomyomas: a systematic review and meta-analysis.
    Lim KJ; Yoon DY; Kim J H ; Cho YK; Kim HJ; Ahn HS; Ahn IM
    Clin Exp Obstet Gynecol; 2016; 43(5):643-649. PubMed ID: 30074311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids.
    Milic A; Asch MR; Hawrylyshyn PA; Allen LM; Colgan TJ; Kachura JR; Hayeems EB
    Cardiovasc Intervent Radiol; 2006; 29(4):694-8. PubMed ID: 16502165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
    Zurawin RK; Fischer JH; Amir L
    J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.
    Ghezzi F; Cromi A; Bergamini V; Scarperi S; Bolis P; Franchi M
    Surg Endosc; 2007 Nov; 21(11):2081-5. PubMed ID: 17514400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safely Introducing New Surgical Devices in Minimally Invasive Gynecologic Surgery: An Argument for Use of the IDEAL Framework.
    Ramanathan A; Davis-Cooper S; Iglesia CB
    J Minim Invasive Gynecol; 2024 Jan; 31(1):21-27. PubMed ID: 37866715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.